Literature DB >> 30201469

Shared decision making for the allergist.

Michael S Blaiss1, Gary C Steven2, Bruce Bender3, Don A Bukstein2, Eli O Meltzer4, Tonya Winders5.   

Abstract

OBJECTIVE: Shared decision making (SDM) is becoming more commonly appreciated and used in medical practice as a way to empower patients who are facing treatment preference-sensitive conditions, such as allergic rhinitis, atopic dermatitis, food allergy, and persistent asthma. The purpose of this review is to educate the allergy health care provider about how SDM works and provide practical advice and allergist-specific SDM resources. DATA SOURCES: PubMed and online patient decision aid resources. STUDY SELECTIONS: Studies and reviews relevant to SDM and patient decision aids relevant to the allergy health care provider were selected for discussion.
RESULTS: There are ethical, practical, economic, and psychological imperatives for the implementation of quality SDM, particularly for chronic diseases. Many benefits and barriers of SDM have been identified and models have been developed to encourage implementation of quality SDM. For the allergy health care provider, SDM for asthma has been shown to improve adherence, outcomes, and patient satisfaction with care. Patient decision aids are useful tools for SDM and have recently been developed for allergen immunotherapy, severe asthma, and atopic dermatitis.
CONCLUSION: Effective SDM has been shown to improve adherence and lead to better outcomes. SDM should be universally implemented as a key component of patient-centered health care. Allergy health care providers should work with their patients to reach treatment decisions that align with their values and preferences.
Copyright © 2018 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Year:  2018        PMID: 30201469     DOI: 10.1016/j.anai.2018.08.019

Source DB:  PubMed          Journal:  Ann Allergy Asthma Immunol        ISSN: 1081-1206            Impact factor:   6.347


  10 in total

Review 1.  Fatal Anaphylaxis: Epidemiology and Risk Factors.

Authors:  Irene Mikhail; David R Stukus; Benjamin T Prince
Journal:  Curr Allergy Asthma Rep       Date:  2021-04-07       Impact factor: 4.806

2.  Preference for Immunotherapy with Tablets by People with Allergic Rhinitis.

Authors:  Mike Tankersley; Tonya Winders; Mark Aagren; Henrik Brandi; Mikkel Hasse Pedersen; Anne Sofie Ledgaard Loftager; Mette Bøgelund
Journal:  Patient Prefer Adherence       Date:  2021-11-18       Impact factor: 2.711

Review 3.  Achieving the Quadruple Aim to deliver value-based allergy care in an ever-evolving health care system.

Authors:  Edward G A Iglesia; Matthew Greenhawt; Marcus S Shaker
Journal:  Ann Allergy Asthma Immunol       Date:  2020-04-11       Impact factor: 6.347

4.  A study to assess current approaches of allergists in European countries diagnosing and managing children and adolescents with peanut allergy.

Authors:  Vibha Sharma; Jennifer Jobrack; Wendy Cerenzia; Stephen Tilles; Robert Ryan; Regina Sih-Meynier; Stefan Zeitler; Michael Manning
Journal:  PLoS One       Date:  2020-12-03       Impact factor: 3.240

5.  Psychometric properties of the simplified Chinese version of the observer OPTION5 scale.

Authors:  Zhaojuan Chen; Xuefei Bai; Guanghui Jin; Xin Tao; Guowei Huang; Yali Zhao
Journal:  BMC Fam Pract       Date:  2020-12-06       Impact factor: 2.497

6.  Optimal Management of Hereditary Angioedema: Shared Decision-Making.

Authors:  Aleena Banerji; John Anderson; Douglas T Johnston
Journal:  J Asthma Allergy       Date:  2021-02-09

7.  Preference for sublingual immunotherapy with tablets in a Spanish population with allergic rhinitis.

Authors:  Mette Bøgelund; Ana Rosado Ingelmo; Jose María Ausín Ruiz; Adolfo Galán Vivó; Henrik Brandi; Mikkel Hasse Pedersen; Anne Sofie Ledgaard Loftager; Mark Aagren
Journal:  Clin Transl Allergy       Date:  2022-02-04       Impact factor: 5.871

8.  Are there differences in the treatment information received to support guided self-management between asthma and allergy patients?: A community pharmacy survey in Finland.

Authors:  Juha Markus Heikkilä; Paula Bergman; Juha Jantunen; Johanna Salimäki; Paula Kauppi; Marika Pohjanoksa-Mäntylä
Journal:  Explor Res Clin Soc Pharm       Date:  2021-06-24

Review 9.  Managing food allergy: GA2LEN guideline 2022.

Authors:  Antonella Muraro; Debra de Silva; Susanne Halken; Margitta Worm; Ekaterina Khaleva; Stefania Arasi; Audrey Dunn-Galvin; Bright I Nwaru; Nicolette W De Jong; Pablo Rodríguez Del Río; Paul J Turner; Pete Smith; Philippe Begin; Elizabeth Angier; Hasan Arshad; Barbara Ballmer-Weber; Kirsten Beyer; Carsten Bindslev-Jensen; Antonella Cianferoni; Céline Demoulin; Antoine Deschildre; Motohiro Ebisawa; Maria Montserrat Fernandez-Rivas; Alessandro Fiocchi; Bertine Flokstra-de Blok; Jennifer Gerdts; Josefine Gradman; Kate Grimshaw; Carla Jones; Susanne Lau; Richard Loh; Montserrat Alvaro Lozano; Mika Makela; Mary Jane Marchisotto; Rosan Meyer; Clare Mills; Caroline Nilsson; Anna Nowak-Wegrzyn; Ulugbek Nurmatov; Giovanni Pajno; Marcia Podestà; Lars K Poulsen; Hugh A Sampson; Angel Sanchez; Sabine Schnadt; Hania Szajewska; Ronald Van Ree; Carina Venter; Berber Vlieg-Boerstra; Amena Warner; Gary Wong; Robert Wood; Torsten Zuberbier; Graham Roberts
Journal:  World Allergy Organ J       Date:  2022-09-07       Impact factor: 5.516

10.  Asthma Exacerbation Prediction and Risk Factor Analysis Based on a Time-Sensitive, Attentive Neural Network: Retrospective Cohort Study.

Authors:  Yang Xiang; Hangyu Ji; Yujia Zhou; Fang Li; Jingcheng Du; Laila Rasmy; Stephen Wu; W Jim Zheng; Hua Xu; Degui Zhi; Yaoyun Zhang; Cui Tao
Journal:  J Med Internet Res       Date:  2020-07-31       Impact factor: 5.428

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.